[
    [
        {
            "time": "",
            "original_text": "华大基因(300676)2020年三季报点评：新冠检测试剂需求持续旺盛 常规业务逐步恢复",
            "features": {
                "keywords": [
                    "华大基因",
                    "三季报",
                    "新冠检测试剂",
                    "需求旺盛",
                    "常规业务",
                    "逐步恢复"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因(300676)2020年三季报点评：新冠检测试剂需求持续旺盛 常规业务逐步恢复",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]